I migliori medici di CyberKnife per il tumore polmonare in Israele — TOP-4 medici

Responsabile dell'Unità di Oncologia dei Tessuti Molli e delle Ossa al Sourasky Medical Center – specializzato in trattamenti avanzati per il cancro ai polmoni, incluso il CyberKnife.

• Oltre 25 anni di esperienza in oncologia
• Fellowship in sarcoma presso l'Institut Gustave Roussy, Parigi
• Membro della facoltà del gruppo ESMO Sarcoma
• Ricerca pubblicata sull'immunologia dei tumori e le neoplasie ossee

Il Dott. Ari Raphael guida una ricerca pionieristica sul cancro ai polmoni con più di 5 studi clinici come ricercatore principale, incluse tecniche avanzate di profilazione genomica presso il Sourasky Medical Center.

• Specializzato in neoplasie toraciche e profilazione genomica completa
• Ricercatore principale per studi innovativi su immunoterapia e applicazioni della biopsia liquida
• Moderatore del Molecular Tumor Board per la Israeli Lung Cancer Society
• Formazione presso il Guy's Hospital London in studi sul cancro ai polmoni in fase iniziale
• Onorato con finanziamenti alla ricerca e riconoscimenti per l'insegnamento in oncologia

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.